RXO
265 hedge funds and large institutions have $2.73B invested in RXO in 2025 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 101 increasing their positions, 76 reducing their positions, and 40 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 76
2.95% more ownership
Funds ownership: 105.43% → 108.38% (+3%)
1% more capital invested
Capital invested by funds: $2.72B → $2.73B (+$17M)
0% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 40
1% less funds holding
Funds holding: 267 → 265 (-2)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
89% less call options, than puts
Call options by funds: $1.75M | Put options by funds: $15.7M
Top Buyers
| 1 |
FC
Finepoint Capital
Boston,
Massachusetts
|
+$117M |
| 2 |
BlackRock
New York
|
+$28.4M |
| 3 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$19.3M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$17.9M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$11.9M |
Top Sellers
RXO Hedge Fund Activity: Q3 2025 in Review
265 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in RXO (RXO) for Q3 2025, worth a combined $2.73B — up 0.63% from $2.72B a quarter earlier.
Fund positioning in RXO was balanced in Q3 2025: 40 funds opened new positions, 40 closed out, 101 added to existing stakes and 76 trimmed.
The largest buyer was Finepoint Capital, opening a new position worth an estimated $117M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $36.2M sold.
- 265 institutional investors held RXO (RXO) as of Q3 2025, down from 267 in Q2 2025.
- Funds reported $2.73B of RXO stock for Q3 2025, up 0.63% quarter-over-quarter.
- 40 funds opened new RXO positions in Q3 2025 and 40 closed out, a net change of 0 holders.
- The largest RXO buyer in Q3 2025 was Finepoint Capital, an estimated $117M added.
- The largest RXO seller in Q3 2025 was T. Rowe Price Investment Management, an estimated $36.2M sold.
Based on aggregated 13F filings for Q3 2025.